Cutting edge: Anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4+CD25+ T regulatory cells

Journal of Immunology

Volumn 176, Issue 6, 2006, Pages 3301-3305

  Kohm, Adam P ^a   McMahon, Jeffrey S ^a   Podojil, Joseph R ^a   Begolka, Wendy Smith ^a   DeGutes, Mathew ^a   Kasprowicz, Deborah J ^b   Ziegler, Steven F ^b   Miller, Stephen D ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b BENAROYA RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; CD4 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; MESSENGER RNA; TRANSCRIPTION FACTOR FOXP3;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; GENE EXPRESSION; IMMUNE SYSTEM; IN VIVO STUDY; INJECTION; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 33644841622     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.6.3301     Document Type: Article

References (16)

1. von Boehmer, H. 2005. Mechanisms of suppression by suppressor T cells. Nat. Immunol. 6: 338-344.
2. + suppressor T cells: More questions than answers. Nat. Rev. Immunol. 2: 389-400.
3. + regulatory T cells. Nat. Immunol. 4: 330-336.
4. + T cells via IL-2 dependent mechanisms. Cell. Immunol. 235: 56-64.
5. + T cell suppressor function. J. Immunol. 172: 6519-6523.
6. + regulatory T cells is necessary, but not sufficient, for induction of organ-specific autoimmune disease. J. Immunol. 168: 5979-5983.
7. Onizuka, S., I. Tawara, J. Shimizu, S. Sakaguchi, T. Fujita, and E. Nakayama. 1999. Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor-α) monoclonal antibody. Cancer Res. 59: 3128-3133.
8. + T cell activation and experimental autoimmune encephalomyelitis. J. Immunol. 172: 4686-4690.
9. Tompkins, S. M., J. Padilla, M. C. Dal Canto, J. P. Ting, L. Van Kaet, and S. D. Miller. 2002. De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis. J. Immunol. 168: 4173-4183.
10. Lan, R. Y., A. A. Ansari, Z. X. Lian, and M. E. Gershwin. 2005. Regulatory T cells: development, function and role in autoimmunity. Autoimmun. Rev. 4: 351-363.
11. + regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J. Immunol. 169: 4712-4716.
12. + regulatory T cells. Novartis Found. Symp. 252: 45-52.
13. + T cell un responsive ness and functional reversal of established experimental autoimmune encephalomyelitis. J. Immunol. 174: 4525-4534.
14. Karlsson, H., and L. Nassberger. 1995. Influence of compounds affecting synthesis, modification and transport of proteins on the expression and release of interleukin-2 receptor. Immunol. Cell Bioi. 73: 81-88.
15. Mullberg, J., C. T. Rauch, M. F. Wolfson, B. Castner, J. N. Fitzner, C. Otten-Evans, K. M. Mohler, D. Cosman, and R. A. Black. 1997. Further evidence for a common mechanism for shedding of cell surface proteins. FEBS Lett. 401: 235-238.
16. Raqib, R., A. A. Lindberg, L. Bjork, P. K. Bardhan, B. Wretlind, U. Andersson, and J. Andersson. 1995. Down-regulation of γ-interferon, tumor necrosis factor type I, interleukin 1 (IL-1) type I, IL-3, IL-4, and transforming growth factor β type I receptors at the local site during the acute phase of Shigella infection. Infect. Immun. 63: 3079-3087.